Abstract: The present disclosure relates to: a lithium secondary battery including a positive electrode, a separator, and a negative electrode, the lithium secondary battery being injected with an electrolyte solution containing a eutectic mixture of succinonitrile and lithium salt as a solvent; and a method for manufacturing the lithium secondary battery.

Abstract: A non-aqueous electrolyte solution for a lithium secondary battery and a lithium secondary battery including the same are disclosed herein. In some embodiments, a non-aqueous electrolyte includes a lithium salt, a non-aqueous solvent, a compound represented by Formula 1, and a compound represented by Formula 2, wherein the compound represented by Formula 1 and the compound represented by Formula 2 are included in a volume ratio of 1:0.1 to 1:1.5. Also, a lithium secondary battery including the non-aqueous electrolyte has improved high-temperature storage safety.

Abstract: The present invention relates to a composition comprising paeonol of formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient for inhibiting angiogenesis, or for enhancing radiosensitization. The present invention also relates to novel use of paeonol of formula (I) or a pharmaceutically acceptable salt thereof for the manufacture of a composition for inhibiting angiogenesis, or for the manufacture of a composition for enhancing radiosensitization. Also, the present invention relates to a method for inhibiting angiogenesis which comprises administrating to a subject in need thereof an effective amount of paeonol of formula (I) or a pharmaceutically acceptable salt thereof, or a method for enhancing radiosensitization which comprises administrating an effective amount of paeonol of formula (I) or pharmaceutically acceptable salts thereof to a subject in need of radiotherapy.

Abstract: The present disclosure relates to an electrochemical device and a battery module having improved anti-vibration. In the electrochemical device and the battery module according to one embodiment of the present disclosure which are mounted in electrically powered tools or other equipments, tap holders for providing vibration-resistance are provided on the outer surface of a cathode tap or an anode tap exposed to the outside of the electrochemical device or the battery module, thereby dispersing external force applied to the cathode tap or the anode tap to prevent the cathode tap or the anode tap from being damaged, and immobilizing the cathode tap or the anode tap to prevent an external short circuit, and eventually to improve the stability of the electrochemical device and the battery module.

Abstract: The present disclosure refers to a lithium secondary battery comprising Li2NiO2 in a cathode active material so as to improve the phenomenon that the capacity retention ratio decreases at initial cycles when using an anode active material selected from the group consisting of Si, SiC, SiOx (0<x<2), Sn, SnO2, Sb, Ge and a mixture thereof. The lithium secondary battery according to the present disclosure can substantially improve the decrease of a capacity retention ratio during initial cycles.

Abstract: The present disclosure refers to a lithium secondary battery comprising Li2NiO2 in a cathode active material so as to improve the phenomenon that the capacity retention ratio decreases at initial cycles when using an anode active material selected from the group consisting of Si, SiC, SiOx (0<x<2), Sn, SnO2, Sb, Ge and a mixture thereof. The lithium secondary battery according to the present disclosure can substantially improve the decrease of a capacity retention ratio during initial cycles.

Abstract: The present disclosure relates to an electrochemical device and a battery module having improved anti-vibration. In the electrochemical device and the battery module according to one embodiment of the present disclosure which are mounted in electrically powered tools or other equipments, tap holders for providing vibration-resistance are provided on the outer surface of a cathode tap or an anode tap exposed to the outside of the electrochemical device or the battery module, thereby dispersing external force applied to the cathode tap or the anode tap to prevent the cathode tap or the anode tap from being damaged, and immobilizing the cathode tap or the anode tap to prevent an external short circuit, and eventually to improve the stability of the electrochemical device and the battery module.

Abstract: Disclosed herein is a feed-forward ring oscillator. The feed-forward ring oscillator includes a plurality of delay cells for receiving a first differential input signal pair and a second differential input signal pair, and outputting a differential output signal pair. The delay cells are connected in a ring shape. Each of the delay cells receives a differential output signal pair of a delay cell of a previous stage as a first differential input signal pair and receives a differential output signal pair of a delay cell of a stage before the previous stage as a second differential input signal pair. Each of the delay cells comprises multiple independent gate field-effect transistors.

Abstract: Disclosed herein is a feed-forward ring oscillator. The feed-forward ring oscillator includes a plurality of delay cells for receiving a first differential input signal pair and a second differential input signal pair, and outputting a differential output signal pair. The delay cells are connected in a ring shape. Each of the delay cells receives a differential output signal pair of a delay cell of a previous stage as a first differential input signal pair and receives a differential output signal pair of a delay cell of a stage before the previous stage as a second differential input signal pair. Each of the delay cells comprises multiple independent gate field-effect transistors.

Abstract: The present disclosure relates to a Panax ginseng polysaccharide extract, which is useful for liver protection or for the prevention and treatment of liver diseases, and a method for preparing the same. Further, the present invention relates to a composition for the prevention and treatment of liver diseases, comprising the Panax ginseng polysaccharide extract as an active ingredient, and a food composition comprising the same.

Abstract: The present invention relates to compositions containing an extract of processed Panax genus plant and ginsenosides isolated therefrom for treat thrombotic diseases in human or mammal, the method for treating said diseases using thereby and the use thereof.

Abstract: The present invention relates to a composition comprising paeonol of formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient for inhibiting angiogenesis, or for enhancing radiosensitization. The present invention also relates to novel use of paeonol of formula (I) or a pharmaceutically acceptable salt thereof for the manufacture of a composition for inhibiting angiogenesis, or for the manufacture of a composition for enhancing radiosensitization. Also, the present invention relates to a method for inhibiting angiogenesis which comprises administrating to a subject in need thereof an effective amount of paeonol of formula (I) or a pharmaceutically acceptable salt thereof, or a method for enhancing radiosensitization which comprises administrating an effective amount of paeonol of formula (I) or pharmaceutically acceptable salts thereof to a subject in need of radiotherapy.

Abstract: The disclosure concerns novel enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts, their preparations and pharmaceutical compositions. The enantiomers of tetrahydroisoquinoline derivatives are provided which are useful in stimulating heart rate and hypotensive activity, inhibitory activity against platelet aggregation, and suppressive against inducible NO synthase. The enantiomers of tetrahydroisoquinoline derivatives and their pharmaceutically acceptable salts are effective for treating congestive heart failure, hypertension, thrombosis, inflammation, septicemia, cardiac insufficiency, and disseminated intravascular coagulopathy.

Abstract: Disclosed are pharmaceutical compositions for the treatment and prophylaxis of heart failure, thrombosis, iNOS-induced tissue injury, septicemia, and disseminated intravascular coagulation. The compositions comprise, as a pharmacologically active ingredient, the compounds represented by the following chemical formulas 1 and 2, each of them showing heart stimulating activity, hypotensive activity, inhibitory activity against platelet aggregation, and suppressive activity against iNOS expression in combination and at once.

Abstract: The present invention relates to a polysaccharide composition having the hematopoietic, myeloprotecting, antitumor immune cell generating, and radiosensitizing activities extracted from the roots of Panax ginseng prepared by the steps of: i) obtaining the residue by extracting 1 wt part of ginseng roots with 2˜4 wt part of methanol; ii) extracting and obtaining the water soluble fraction from the residue in step i) using 3˜5 wt part of distilled water; iii) freeze-drying the obtained water soluble fraction in step ii); iv) obtaining the inner fraction using the dialysis membrane after obtaining the insoluble fraction to the 40% of ethanol from freeze-dried fraction in step iii); v) obtaining the 6 fractions by sephacryl S-500 gel chromatography; and vi) purifying the polysaccharide by DEAE-sephadex A-50 chromatography.

Abstract: The invention herein relates to a pharmaceutical composition comprising ticlopidine and Ginkgo biloba extract. In detail, as an anti-thrombotic preparation, the pharmaceutical composition comprising said ticlopidine and Ginkgo biloba extract with the PAF-antagonistic and anti-oxidant actions is used in combination to naturally suppress the neutropenia and agranulocytosis caused by the toxicity resulting from the repeated use of ticlopidine alone.